Clinical Trial Update: Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI [Phase 2]

View source ↗

Summary

Phase 2 trial investigating serotonin receptor activity for sleep apnea in patients with spinal cord injury has completed with posted results as of 2020-04-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep-disordered Breathing
• Spinal Cord Injury

Snippet

Sponsor: VA Office of Research and Development | Conditions: Spinal Cord Injury, Sleep Disordered Breathing | Phase 2 | Status: COMPLETED | Results posted: 2020-04-09